ACC: Treat-to-Target LDL-C Strategy Noninferior to High-Intensity Statins

TUESDAY, March 7, 2023 -- For patients with coronary artery disease, a treat-to-target low-density lipoprotein cholesterol (LDL-C) strategy is noninferior to high-intensity statin therapy, according to a study published online March 6 in the Journal...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news